CDEK
← All organizations

NPS Pharma

For profitContributed to NME

Also known as: NPS PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2001

First marketed drug

Dec 20, 2012

First NDA

Dec 20, 2012

Last known activity

Nov 1, 2013

Acquired by Shire → Takeda on Jan 11, 2015

Timeline

1980s

  1. Jul 1, 1986

    NPS Pharma— Founded

1990s

  1. Jan 1, 1999

    Allelix— Acquired

2000s

  1. Jan 1, 2009

    Enzon— Acquired

2010s

  1. Dec 21, 2012

    teduglutide— NDA Secondary Org

  2. Jan 11, 2015

    Shire— Acquired By

  3. Jan 23, 2015

    parathyroid hormone— Marketing Organization

  4. Jan 24, 2015

    parathyroid hormone— NDA Organization

  5. Dec 3, 2018

    Takeda— Now

Drugs by trial phase (31 distinct, 39 trials)

Phase 4 (0 own, 1 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (15)

Details

Founded
Bedminster, NJ, US Jul 1, 1986
First NDA
Dec 20, 2012
Last known activity
Nov 1, 2013

Designations held

  • Orphan drug

Notes

Shire acquires NPA Pharma 11 Jan 2015